The discovery of a previously unknown molecular target has inspired what may become a therapeutic breakthrough for people with glioblastoma, the most common and aggressive brain cancer.
Sep 11, 2023
0
92
Studying the complex interactions between synaptic nerve endings as well as their development has now become much easier. Thanks to a method developed by scientists of the Karl Landsteiner University of Health Sciences (KL ...
Aug 29, 2023
0
40
Currently, it is a difficult and laborious process to place two cells in contact with each other to examine their binding characteristics. It is however a necessary step in understanding how cells interact in the hopes of ...
Aug 18, 2023
0
62
Herpes viruses are treacherous: once you are infected, you can never get rid of the virus. This is because herpes viruses lie dormant in certain host cells in the body for a lifetime. Almost every adult unknowingly carries ...
Aug 7, 2023
0
36
Researchers at the Francis Crick Institute and King's College London have revealed the complex interactions between cancer and the immune cells that surround a tumor, with the potential to inform how patients will respond ...
Jun 9, 2023
0
73
Researchers at Gladstone Institutes, the Broad Institute of MIT and Harvard, and Dana-Farber Cancer Institute have turned to artificial intelligence (AI) to help them understand how large networks of interconnected human ...
May 31, 2023
0
143
Because serotonin is one of the primary chemicals the brain uses to influence mood and behavior, it is also the most common target of psychiatric drugs. To improve those drugs and to invent better ones, scientists need to ...
May 15, 2023
0
61
SpaceMarkers, a new machine learning software developed by researchers at the Johns Hopkins Convergence Institute and the Johns Hopkins Kimmel Cancer Center, can identify molecular interactions among distinct types of cells ...
May 11, 2023
0
61
Researchers at University of Galway studying cell interactions in bowel cancer have identified innovative strategies to enhance how the body and drug treatments fight the disease.
May 11, 2023
0
36
A team of Harvard and Sloan Kettering scientists has developed compounds that can target and degrade proteins associated with acute myeloid leukemia (AML) and nearly doubled the life expectancy of mice with cancer in laboratory ...
Apr 3, 2023
0
74
